On June 2, MPCC’s Board of Directors met in the margins of the Critérium du Dauphiné. Important topics were discussed – ketones use was the main concern addressed.

International bodies still have not reported any progress on such an important topic as ketones. Our members are worried of being forced to deal with this failure to take a stand.

On May 3, responding to MPCC’s demands, UCI confirmed that it was aware of the prevalent use of ketone-based dietary supplements into cycling. Regarding the current situation, UCI ensured to make a quick decision and to raise awareness among the stakeholders on this topic.

A few weeks before the Grand Départ of the Tour de France, MPCC deplores such a damaging situation. The Board of Directors wants to express its support to our member teams, as they are sticking to the clear line they set: to commit to the non-use of ketones.

Another important topic was the implementation of a the new UCI regulation on glucocorticoids use. MPCC’s members are still waiting for information on how this regulation will be shaped.

In the meantine, MPCC will continue to carry out cortisol level tests among its member teams. Since the beginning of the year, 25 MPCC teams have been tested, for a total of 177 riders taking part in 4 different races. No abnormally low values were found.

MPCC’s Board of Directors also noted all the members of the movement have respected the very strict regulation they committed to.

During this meeting, Vincent Lavenu (AG2R-Citroën Team) was designated Vice-President of MPCC. He will share this position with Iwan Spekenbrink (Team DSM).